Clinical Trial Update: Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 comparative bioequivalence study comparing Wockhardt Listro Mix 75/25 and Humalog Mix75/25 in healthy subjects has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Humalog Mix75/25 (Insulin lispro)
• Listro Mix 75/25 (insulin lispro mix 75/25)

Snippet

Sponsor: Wockhardt | Conditions: Bioequivalence in Healthy Subjects | Phase 1 | Status: WITHDRAWN